The global structural heart procedures market size was estimated at USD 16.7 billion in 2025 and is projected to reach USD 36.4 billion by 2033, growing at a CAGR of 10.3% from 2026 to 2033. Key factors driving this market include the rising global prevalence of structural heart diseases and broader cardiovascular disorders, along with the increasing demand for minimally invasive surgical procedures. As populations age and the incidence of conditions such as aortic stenosis, mitral regurgitation, congenital heart defects, and left atrial appendage abnormalities continues to grow, healthcare providers are increasingly adopting advanced structural heart interventions that offer effective treatment with reduced procedural risk and shorter recovery times.
Structural heart procedures encompass a range of catheter-based and surgical interventions designed to repair or replace damaged heart valves and correct anatomical abnormalities within the heart. These procedures include transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair and replacement, left atrial appendage closure, and septal defect closure. Compared with conventional open-heart surgery, minimally invasive structural heart procedures generally involve smaller incisions, lower complication rates, shorter hospital stays, and faster return to daily activities. These benefits are driving widespread adoption among physicians and patients, particularly in elderly and high-risk populations.
According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease stands at approximately 7,179 cases per 100,000 individuals, highlighting the substantial and persistent worldwide burden of heart-related conditions. This high prevalence underscores the urgent need for effective and accessible treatment options capable of addressing a broad spectrum of structural and functional cardiac disorders. As cardiovascular disease remains one of the leading causes of morbidity and mortality globally, demand for advanced diagnostic tools and therapeutic interventions continues to rise.
The growing clinical acceptance of minimally invasive structural heart procedures is also being supported by technological advancements in imaging systems, catheter designs, valve materials, and procedural planning software. These innovations are improving treatment precision, expanding eligibility to a broader patient population, and enhancing long-term outcomes. In addition, increasing awareness among healthcare professionals, expanding reimbursement coverage, and greater availability of specialized cardiac centers are contributing to the rapid adoption of structural heart procedures across both developed and emerging healthcare markets.
Key Market Trends & Insights
• The North America structural heart procedures market dominated the global market in 2025, accounting for the largest revenue share of 52.5%. The region’s leadership is supported by a highly developed healthcare infrastructure, widespread adoption of advanced cardiovascular technologies, and strong clinical expertise in minimally invasive cardiac interventions. North America also benefits from favorable reimbursement systems, significant investments in medical research, and a large patient population affected by structural heart disorders such as aortic stenosis and mitral valve disease. The presence of leading medical device manufacturers and specialized cardiac centers has further strengthened the region’s dominant position in the global market.
• The United States dominated the structural heart procedures market in 2025. The country’s leading position can be attributed to its high prevalence of cardiovascular disease, rapid adoption of innovative transcatheter technologies, and strong regulatory and reimbursement support for advanced cardiac procedures. The United States is home to numerous top-tier hospitals and heart institutes with extensive experience in performing structural heart interventions. In addition, robust clinical trial activity and ongoing physician training programs have accelerated the integration of new devices and treatment approaches into routine cardiovascular care.
• In terms of the procedure segment, the TAVR (Transcatheter Aortic Valve Replacement) segment held the largest revenue share in 2025. TAVR has become one of the most widely adopted structural heart procedures because it provides a minimally invasive alternative to open-heart surgery for patients with severe aortic stenosis. The procedure involves replacing a diseased aortic valve using a catheter-based approach, resulting in shorter hospital stays, faster recovery, and reduced procedural risk, especially for elderly and high-risk patients. Expanding clinical evidence and broader patient eligibility criteria have contributed significantly to the segment’s leadership.
• In terms of the indication segment, the aortic stenosis segment held the largest revenue share in 2025. Aortic stenosis is one of the most common and serious valvular heart diseases, particularly among aging populations. The condition restricts blood flow from the heart and can lead to symptoms such as chest pain, shortness of breath, and heart failure if left untreated. The increasing prevalence of this disorder, combined with growing use of transcatheter valve replacement technologies, has made aortic stenosis the leading indication for structural heart procedures.
• In terms of end use, the hospitals segment dominated the market in 2025 with a revenue share of 67.4%. Hospitals remain the primary setting for structural heart procedures because they possess the specialized infrastructure, multidisciplinary cardiac teams, and advanced imaging and surgical capabilities required for these complex interventions. Many hospitals also operate dedicated structural heart programs and hybrid operating rooms designed to support transcatheter and surgical procedures. Their ability to provide comprehensive preoperative evaluation, procedural care, and postoperative monitoring has made hospitals the largest end-use segment in the market.
Looking for more specific insights? Customize this report to suite your business needs
Key Structural Heart Procedures Company Insights
Key participants in the structural heart procedures market are focusing on devising innovative business growth strategies to strengthen their competitive positions and expand their presence across global healthcare markets. The industry is characterized by continuous technological advancement, increasing clinical adoption, and strong competition among leading medical device manufacturers that specialize in transcatheter valves, closure devices, delivery systems, and related cardiovascular technologies. To capitalize on growing demand for minimally invasive cardiac interventions, companies are implementing a range of strategic initiatives designed to enhance product capabilities, broaden market access, and support long-term revenue growth.
One of the primary strategies being pursued is product portfolio expansion. Companies are investing heavily in research and development to introduce next-generation devices with improved durability, precision, and ease of use. These innovations include advanced transcatheter aortic and mitral valve systems, left atrial appendage closure devices, and specialized catheter-based tools that enable physicians to treat a wider range of structural heart conditions. By expanding their portfolios, manufacturers can address diverse clinical needs and strengthen their ability to serve both established and emerging indications.
Partnerships and collaborations are also playing a crucial role in accelerating innovation and commercialization. Market participants are forming alliances with hospitals, research institutions, and technology companies to conduct clinical studies, develop new treatment approaches, and enhance physician training. These collaborations help companies validate product performance, gain regulatory approvals, and promote broader adoption of structural heart procedures in clinical practice. Strategic partnerships with distributors and healthcare providers also improve market penetration and customer engagement across different regions.
Mergers and acquisitions remain an important tool for expanding technological capabilities and entering new market segments. By acquiring innovative startups and complementary businesses, larger companies can gain access to proprietary technologies, experienced research teams, and established customer relationships. This approach enables faster product development and allows organizations to strengthen their positions in highly specialized areas of cardiovascular care.
Business footprint expansions are another key priority for industry participants. Companies are increasing their presence in emerging markets by establishing local subsidiaries, expanding manufacturing capacity, and strengthening distribution networks. These efforts are aimed at improving product availability and supporting the growing adoption of minimally invasive structural heart procedures worldwide. Collectively, these strategic initiatives are enabling leading companies to enhance innovation, improve clinical outcomes, and maintain a strong competitive advantage in the structural heart procedures market.
Key Structural Heart Procedures Companies:
The following key companies have been profiled for this study on the structural heart procedures market.
• Abbott (St. Jude Medical)
• Medtronic
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Lepu Medical Technology
• LivaNova PLC
• ATRICURE, INC
• Anteris Technologies
• Micro Interventional Devices, Incorporated
• JenaValve
• W. L. Gore & Associates, Inc.
• Occlutech
• Comed BV
Grand View Research offers
√ Focused market intelligence reports on specific geographies or high-growth segments.
√ Extended forecast timelines for long-term planning.
√ Competitor Benchmarking and Supply Chain Analysis
√ Inclusion of regulatory and policy assessments.
√ Inclusion of custom data models, KPIs, or applications unique to your business
√ Specific high-impact Data Decks and Tables to support effective decision making
And much more…
Looking for a report customized to your requirements? Explore our Custom Research Offering
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt